Literature DB >> 21865351

Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males.

Maria T Vamvini1, Konstantinos N Aronis, John P Chamberland, Christos S Mantzoros.   

Abstract

CONTEXT: Activin A, myostatin, and follistatin have recently emerged as important regulatory molecules of reproduction and the musculoskeletal system. Little is known, however, about their day/night patterns of secretion and their physiological regulation by energy availability.
OBJECTIVE: The objective of the study was to explore day/night patterns of secretion and assess whether energy deprivation alters circulating levels of activin A, myostatin, follistatin, and cortisol and to examine whether leptin may mediate this effect. DESIGN, SETTING AND PATIENTS, AND
INTERVENTIONS: Seven healthy lean men (aged 23.2 ± 3.7 yr, body mass index 23.6 ± 1.7 kg/m(2)) were studied for 72 h under three different conditions: on their baseline/isocaloric diet and in a complete fasting state with administration of either placebo or metreleptin. The two fasting studies were randomized and double blinded. Blood samples were obtained every 15 min from 0800 h on d 3 until 0800 h on d 4 and pooled hourly. MAIN OUTCOME MEASURES: Serum concentrations of activin A, myostatin, follistatin, cortisol, and leptin were measured.
RESULTS: In contrast to cortisol, we demonstrated no day/night pattern of activin A, myostatin, and follistatin secretion. Activin A concentrations decreased significantly in response to energy deprivation (P < 0.01). Follistatin and cortisol concentrations increased significantly (P < 0.01 and P < 0.01, respectively). Myostatin remained unaffected (P = 0.40). Leptin administration reversed cortisol response (P < 0.01) but failed to alter activin A, follistatin, or myostatin concentrations.
CONCLUSIONS: Unlike cortisol, there is no day/night variation in the concentrations of activin A, myostatin, and follistatin in healthy young males. Although energy deprivation-induced cortisol changes are leptin mediated, the changes in follistatin and activin A concentrations occur through a leptin-independent pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865351      PMCID: PMC3205881          DOI: 10.1210/jc.2011-1665

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  42 in total

1.  Evolutionary trace analysis of TGF-beta and related growth factors: implications for site-directed mutagenesis.

Authors:  C A Innis; J Shi; T L Blundell
Journal:  Protein Eng       Date:  2000-12

2.  Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.

Authors:  M L Heiman; R S Ahima; L S Craft; B Schoner; T W Stephens; J S Flier
Journal:  Endocrinology       Date:  1997-09       Impact factor: 4.736

3.  Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans.

Authors:  Jean L Chan; Joseph E Mietus; Patricia M Raciti; Ary L Goldberger; Christos S Mantzoros
Journal:  Clin Endocrinol (Oxf)       Date:  2007-01       Impact factor: 3.478

4.  Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects.

Authors:  Rochelle Goldsmith; Denis R Joanisse; Dympna Gallagher; Katherine Pavlovich; Elisabeth Shamoon; Rudolph L Leibel; Michael Rosenbaum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-04       Impact factor: 3.619

5.  Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

Authors:  Elizabeth Sienkiewicz; Faidon Magkos; Konstantinos N Aronis; Mary Brinkoetter; John P Chamberland; Sharon Chou; Kalliopi M Arampatzi; Chuanyun Gao; Anastasia Koniaris; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-07-07       Impact factor: 8.694

6.  Leptin is an effective treatment for hypothalamic amenorrhea.

Authors:  Sharon H Chou; John P Chamberland; Xiaowen Liu; Giuseppe Matarese; Chuanyun Gao; Rianna Stefanakis; Mary T Brinkoetter; Huizhi Gong; Kalliopi Arampatzi; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

Review 7.  Narrative review: the role of leptin in human physiology: emerging clinical applications.

Authors:  Theodore Kelesidis; Iosif Kelesidis; Sharon Chou; Christos S Mantzoros
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

8.  The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.

Authors:  Jennifer N Cash; Carlis A Rejon; Alexandra C McPherron; Daniel J Bernard; Thomas B Thompson
Journal:  EMBO J       Date:  2009-07-30       Impact factor: 11.598

9.  Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice.

Authors:  Neira Sáinz; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

10.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

Authors:  I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

View more
  21 in total

1.  Research advances in metabolism 2016.

Authors:  Nikolaos Perakakis; Olivia M Farr; Dario Tuccinardi; Jagriti Upadhyay; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-11-06       Impact factor: 8.694

Review 2.  Hepatokines-a novel group of exercise factors.

Authors:  Cora Weigert; Miriam Hoene; Peter Plomgaard
Journal:  Pflugers Arch       Date:  2018-10-18       Impact factor: 3.657

3.  Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.

Authors:  Stergios A Polyzos; Nikolaos Perakakis; Chrysoula Boutari; Jannis Kountouras; Wael Ghaly; Athanasios D Anastasilakis; Asterios Karagiannis; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

4.  Association of Gnrhr mRNA With the Stem Cell Determinant Musashi: A Mechanism for Leptin-Mediated Modulation of GnRHR Expression.

Authors:  Angela K Odle; Helen Beneš; Andrea Melgar Castillo; Noor Akhter; Mohsin Syed; Anessa Haney; Melody Allensworth-James; Linda Hardy; Benjamin Winter; Ragul Manoharan; Raiyan Syed; Melanie C MacNicol; Angus M MacNicol; Gwen V Childs
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

5.  Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans.

Authors:  John P Chamberland; Reena L Berman; Konstantinos N Aronis; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2013-09-13       Impact factor: 6.664

6.  FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.

Authors:  Joo Young Huh; Grigorios Panagiotou; Vassilis Mougios; Mary Brinkoetter; Maria T Vamvini; Benjamin E Schneider; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-09-25       Impact factor: 8.694

7.  Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.

Authors:  Nikolaos Perakakis; Jagriti Upadhyay; Wael Ghaly; Joyce Chen; Pavlina Chrysafi; Athanasios D Anastasilakis; Christos S Mantzoros
Journal:  Metabolism       Date:  2018-05-09       Impact factor: 8.694

8.  Activin A and follistatin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Georgios Α Triantafyllou; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

9.  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Elpida C Skouvaklidou; Georgios Kynigopoulos; Zacharias G Saridakis; Aggeliki Apostolou; Georgios A Triantafyllou; Thomai Karagiozoglou-Lampoudi; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-08       Impact factor: 8.694

10.  Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.

Authors:  Nathan A Ungerleider; Lara M Bonomi; Melissa L Brown; Alan L Schneyer
Journal:  Endocrinology       Date:  2013-03-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.